CEBPA公司
造血
癌症研究
运行x1
白血病
造血干细胞
祖细胞
小RNA
生物
干细胞
基因
突变
免疫学
细胞生物学
遗传学
作者
Mir Farshid Alemdehy,Jurgen R. Haanstra,Hans W. J. de Looper,Paulina M. H. van Strien,Judith Verhagen-Oldenampsen,Yvette Caljouw,Mathijs A. Sanders,Remco M. Hoogenboezem,Arnoud H. de Ru,George M. C. Janssen,Stephanie E. Smetsers,Marc Bierings,Peter A. van Veelen,Marieke von Lindern,Ivo P. Touw,Stefan J. Erkeland
出处
期刊:Blood
[Elsevier BV]
日期:2015-03-17
卷期号:125 (25): 3937-3948
被引量:68
标识
DOI:10.1182/blood-2014-11-612507
摘要
Key Points miR-139-3p and miR-199a-3p, induced by ICL-induced damage, respectively, cause a loss and gain of hematopoietic progenitors. miR-199a-3p is an onco-microRNA (onco-miR) causing AML in a Cebpa-deficient mouse model. Target genes of miR-199a-3p include PRDX6, RUNX1, and SUZ12.
科研通智能强力驱动
Strongly Powered by AbleSci AI